Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Glynn Wilson, CEO, TapImmune Inc
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Tapimmune CEO Glynn Wilson talk about the company.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
combined experience building the own companies|Hadley Harris,Co-Founder,Eniac Ventures
00:10:00
Unlocking the Potential of Generative AI in Healthcare: Expert Perspectives and Innovations | A. Hadi Chaudhry, CEO, CareCloud Inc.
00:10:00
Navigating Economic Uncertainty: Insights from Mansoor Al Mahmoud | Mansoor Al Mahmoud - CEO, Qatar Investment Authority
00:10:00
Cahya Mata Sarawak Berhad highlights CMS Property Development's accomplishments and contributions.
00:10:00
Market Outlook for Long-Short Strategies: Insights from Rajesh Bhatia of ITI Long Short Equity Fund | Rajesh Bhatia - Fund Manager, ITI Long Short Equity Fund
00:10:00
Barclays CEO Talks Business Optimization and Investment Banking Strength | C.S. Venkatakrishnan , CEO , Barclays.
00:10:00
Gold Market Outlook: Navigating Macro Forces and Fed Policy Expectations
00:10:00
This month we interviewed Gillian Alexandre Huart, CEO of ENGIE Energy Access, a leader in Pay-As-You-Go (PAYGo) solutions.
00:10:00
Mr. Salim Ghauri, Founder and CEO of NETSol Technologies, shares his views at Namal University on November 7, 2023.
00:10:00
Exploring Sustainable Investing with Nick Scullion
00:10:00
Lawrence Stroll Unveils Aston Martin's New Vanquish and Dual Market Strategy | Lawrence Stroll, Chairman, Lawrence Stroll Aston Martin Lagonda Global Holdings PLC.
00:10:00
Black Iron: Leading Iron Ore Project Ready for Construction with Strong Economic Fundamentals